文献速递骨质疏松与代谢性骨病创伤骨科

骨密度与小梁骨评分与慢性阻塞性肺疾病男性椎体骨折的独立关联

Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease.
PubMed 文献 · Osteoporos Int · 2017-11-22

这项横断面研究纳入61例男性COPD患者,评估肺功能、椎体骨折、骨密度、小梁骨评分、骨转换标志物及炎症指标。结果显示任何椎体骨折患病率为75.4%,2级或3级骨折为19.7%;在年龄校正后,小梁骨评分与骨密度均为2级或3级椎体骨折的独立决定因素,且小梁骨评分的独立决定因素为hsCRP。

要点

  • 男性COPD患者中任何椎体骨折患病率为75.4%,2级或3级骨折为19.7%。
  • 年龄校正后,小梁骨评分与骨密度均为2级或3级椎体骨折的独立决定因素。
  • hsCRP是除年龄和骨密度外小梁骨评分的唯一独立决定因素。

核心结论

  • 在男性COPD受试者中,骨密度和小梁骨评分均与2级或3级椎体骨折独立相关,涉及不同机制。
  • 由hsCRP升高反映的全身炎症可能参与COPD相关骨质疏松中小梁微结构的恶化,而骨密度下降与体重减轻的关联最强。

研究设计与样本

  • 横断面研究,招募61例男性COPD患者,检查肺功能、椎体骨折、骨密度、小梁骨评分、骨转换标志物和炎症参数。
  • 采用多变量分析检验骨参数的决定因素。

主要发现

  • 任何椎体骨折和2级或3级骨折的患病率分别为75.4%和19.7%。
  • 按骨密度定义的骨质疏松和骨量减少分别存在于37.7%和39.3%的患者中。
  • 与GOLD 1期相比,更高GOLD分期患者的小梁骨评分显著更低。
  • 年龄校正后,小梁骨评分和骨密度均为2级或3级椎体骨折的独立决定因素(OR=0.271,95%CI 0.083-0.888,p=0.031;OR=0.242,95%CI 0.075-0.775,p=0.017)。
  • 小梁骨评分的相关因素包括年龄、骨密度、hsCRP、肺功能参数、甲状旁腺激素和Tracp-5b;在多变量回归分析中,除年龄和骨密度外,hsCRP是小梁骨评分的唯一独立决定因素。

关键数值与推荐

  • 任何椎体骨折患病率为75.4%,2级或3级骨折患病率为19.7%。
  • 骨质疏松和骨量减少按骨密度定义分别占37.7%和39.3%。
  • 小梁骨评分对2级或3级椎体骨折的OR=0.271(95%CI 0.083-0.888,p=0.031),骨密度的OR=0.242(95%CI 0.075-0.775,p=0.017),均经年龄校正。
  • 小梁骨评分的独立决定因素为hsCRP(除年龄和骨密度外);骨密度的独立决定因素包括体重指数和程度较轻的25-羟基维生素D。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Osteoporosis is a major comorbidity of chronic obstructive pulmonary disease (COPD), but the mechanism of bone fragility is unknown. We demonstrated that trabecular bone score, a parameter of bone quality, was associated with systemic inflammation and was a significant determinant of vertebral fracture independent of bone mineral density. INTRODUCTION: COPD is a major cause of secondary osteoporosis. However, the mechanism of bone fragility is unclear. We previously reported that vertebral fracture was highly prevalent in male COPD patients. To obtain clues to the mechanism of COPD-associated osteoporosis, we attempted to identify determinants of prevalent vertebral fracture in this study. METHODS: In this cross-sectional study, we recruited 61 COPD males and examined pulmonary function, vertebral fractures, bone mineral density (BMD), trabecular bone score (TBS), bone turnover markers, and inflammatory parameters. Determinants of the bone parameters were examined by multivariable analyses. RESULTS: The prevalence of any and grade 2 or 3 fractures was 75.4 and 19.7%, respectively. Osteoporosis and osteopenia defined by BMD were present in 37.7 and 39.3%, respectively. TBS was significantly lower in higher Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages compared to GOLD 1. Multivariable logistic regression analysis revealed that both TBS and BMD were independent determinants of grade 2 or 3 vertebral fractures (OR = 0.271, 95%CI 0.083-0.888, p = 0.031; OR = 0.242, 95%CI 0.075-0.775, p = 0.017) after adjustment for age. Correlates of TBS included age, BMD, high-sensitivity C-reactive protein (hsCRP), pulmonary function parameters, parathyroid hormone, and Tracp-5b. In multivariable regression analysis, hsCRP was the only independent determinant of TBS besides age and BMD. In contrast, independent determinants of BMD included body mass index and, to a lesser extent, 25-hydroxyvitamin D. CONCLUSION: Both BMD and TBS were independently associated with grade 2 or 3 vertebral fracture in COPD male subjects, involving distinct mechanisms. Systemic inflammation, as reflected by increased hsCRP levels, may be involved in deterioration of the trabecular microarchitecture in COPD-associated osteoporosis, whereas BMD decline is most strongly associated with weight loss.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Watanabe R, Tai N, Hirano J, et al. Independent association of bone mineral density and trabecular bone score to vertebral fracture in male subjects with chronic obstructive pulmonary disease. Osteoporos Int. 2017. PMID: 29167970. doi:10.1007/s00198-017-4314-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。